CILAG, AG ,   Switzerland

Antifungal agent

Suppositories 50 mg, 150 mg.

Monoclonal antibodies
Concentrate for the preparation of a solution for infusions of 20 mg / ml.
Antineoplastic agents, protein kinase inhibitors
Capsules, 140 mg.
a means of reducing the secretion of the glands of the stomach - the proton pump inhibitor.

Tablets coated with enteric coating 10 mg.


Antiaggregant agent
Solution for intravenous administration of 2 mg / ml in vials.
antipsychotic agent (antipsychotic)
Powder for suspension for intramuscular administration of prolonged action, 25 mg, 37.5 mg and 50 mg.
Contraceptive agent (estrogen + progestogen)

Tablets 250 mcg + 35 mcg.

antibodies monoclonal

Solution for subcutaneous administration, 50 mg / 0.5 ml.

tumor necrosis factor-alpha (TNF-alpha) inhibitors

Solution for subcutaneous administration, 100 mg / 1.0 ml.

Interleukin Inhibitors

Solution for subcutaneous administration.

Psoriasis treatment
A solution for subcutaneous administration is 90 mg / ml.
antiepileptic agent

Capsules, 15 mg and 25 mg.

antiepileptic agent
Capsules, 50 mg.
hematopoiesis stimulant
Solution for intravenous and subcutaneous administration, 20000 IU / 0.5 mL and 40,000 IU / 1 mL;
hematopoiesis stimulant

Solution for intravenous and subcutaneous administration of 1000 IU / 0.5 mL, 2000 IU / 0.5 mL, 4000 IU / 0.4 mL, 10,000 IU / 1 mL